Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Samsung Biologics obtains three global ISO certifications
2022-10-13 19:00
Samsung Biologics unlocks additional capacity for production at its newest Plant 4
2022-10-11 19:00
Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022
2022-09-29 19:00
Samsung Biologics Earns Gold Rating from EcoVadis for Its Sustainability Efforts
2022-09-28 19:00
Frost & Sullivan Institute Recognizes Samsung Biologics with the 2022 Global Enlightened Growth Leadership Award for its Commitment to Sustainable Growth
2022-08-09 21:17
GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine
2022-08-01 21:00
Samsung Biologics Reports Second Quarter 2022 Financial Results
2022-07-27 14:43
Samsung Biologics to purchase land for its second Bio Campus
2022-07-18 19:00
'Sustainable CDMO' Samsung Biologics releases 2022 ESG Report
2022-07-11 19:00
Samsung Biologics Reports First Quarter 2022 Financial Results
2022-04-27 14:42
Samsung Biologics completes full acquisition of Samsung Bioepis
2022-04-20 14:45
Samsung Biologics holds 11th Annual General Meeting of Shareholders
2022-03-29 09:42
Samsung Biologics receives 2022 CMO Leadership Award in all six categories
2022-02-07 20:00
Samsung Biologics reaches agreement with Biogen to acquire full ownership of Samsung Bioepis
2022-01-28 08:10
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2021 Financial Results
2022-01-24 16:25
Samsung Biologics Shares Strategic Roadmap for Sustainable Growth at the 40th Annual JP Morgan Healthcare Conference
2022-01-13 08:52
Moderna COVID-19 Vaccine Manufactured in Korea by Samsung Biologics Receives Marketing Authorization from Ministry of Food and Drug Safety of Korea
2021-12-14 13:34
Samsung Biologics and AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy
2021-12-14 08:55
Samsung Biologics adds to global ISO certifications with Quality Management System
2021-12-07 13:04
GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing
2021-11-24 20:00
1
2
3
4
5